Watch the third of a three-part roundtable series that focus on approaches to accelerating your advanced therapy program by leveraging the combination of innovative technology and deep cross-industry ...
therascreen® KRAS RGQ PCR kit approved as a companion diagnostic to aid in identifying non-small cell lung cancer (NSCLC) patients eligible for treatment with KRAZATI® (adagrasib) KRAS mutations in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback